|
|
Severe Pulmonary Hypertension Associated with COPD: Hemodynamic Improvement with Specific Therapy
Anne Girard
,
Stéphane Jouneau
,
Céline Chabanne
,
Chahéra Khouatra
,
Morgane Lannes
et al.
Journal articles
hal-01239807v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone A French Ancillary Study of PASSPORT
Stéphane Jouneau
,
Anne-Sophie Gamez
,
Julie Traclet
,
Hilario Nunes
,
Sylvain Marchand-Adam
et al.
Journal articles
hal-02119176v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial
Jean-Marc Naccache
,
Stéphane Jouneau
,
Morgane Didier
,
Raphaël Borie
,
Marine Cachanado
et al.
Journal articles
hal-03341590v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial
Julie Mankikian
,
Agnès Caille
,
Martine Reynaud-Gaubert
,
Marie-Sara Agier
,
Julien Bermudez
et al.
Journal articles
hal-04113217v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study
David Montani
,
Marie-Caroline Certain
,
Jason Weatherald
,
Xavier Jaïs
,
Sophie Bulifon
et al.
Journal articles
hal-03810260v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|